ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops novel anticancer therapeutics using its antibody-drug conjugate (ADC) technology, today announced that the Company will host a conference call at 8:00 a.m. ET on Friday, October 25, 2013, to discuss ImmunoGen's financial results for the three-month period ended September 30, 2013. Management also will provide an update on the Company.
To access the live call by phone, dial 913-981-5507; the passcode is 2847961. The call also may be accessed through the Investor Information section of the Company's website, www.immunogen.com. Following the live webcast, a replay of the call will be available at the same location through November 8, 2013.
About ImmunoGen, Inc.
ImmunoGen, Inc. develops targeted anticancer therapeutics. The Company's ADC technology uses a tumor-targeting engineered antibody to deliver one of ImmunoGen's highly potent cancer-cell killing agents specifically to tumor cells. The most advanced compound with ImmunoGen’s ADC technology is Roche’s Kadcyla®, which is marketed in the US by Genentech and is also gaining approvals internationally. ImmunoGen has four wholly owned clinical-stage product candidates, with additional compounds in the clinic through its partnerships with Amgen, Bayer HealthCare, Biotest and Sanofi. More information about the Company can be found at www.immunogen.com.
Kadcyla® is a registered trademark of Genentech, Inc., a member of the Roche Group.
|Agilent Technologies to Host Webcast of First-Quarter Fiscal Year 2014 Financial Results Conference Call (2014/1/30)|
|PriceSmart Announces November Sales; Also Announces Earnings Release and Conference Call Dates for First Quarter Fiscal Year 2014 Financial Results (2013/12/6)|
|Accenture to Host Conference Call Thursday, Dec. 19, to Discuss First-Quarter Fiscal Year 2014 Results (2013/12/4)|
|Marvell Technology Group Ltd. Announces Conference Call to Review Fourth Fiscal Quarter and Fiscal Year 2014 Financial Results (2014/1/29)|
|ViaSat Announces First Quarter Fiscal Year 2014 Results ()|
|Cisco Schedules Conference Call for Q1 Fiscal Year 2014 Financial Results ()|
|Hain Celestial Announces Record First Quarter Fiscal Year 2014 Results ()|
|American Science and Engineering, Inc. Reports Results for First Quarter Fiscal Year 2014 and Declares a Quarterly Dividend (2013/8/5)|
|Biodel Reports Third Quarter Fiscal Year 2013 Financial Results ()|
|Whistler Blackcomb Holdings Inc. Announces Timing of its Fiscal 2013 Fourth Quarter and Year End Financial Results and Conference Call (2013/11/21)|
|Start Premium Trial||Register For Free|
|P||F||Fund Financial Data (13,000+ funds)|
|P||F||Stock Financial Data (7,000+ stocks)|
|P||F||Stock and Fund Screeners (basic)|
|P||F||Investing Articles and Market Commentary|
|P||F||Articles Archive (>30 days)|
|P||F||Discuss (dozens of stock, fund, bond, and general bulletin boards)|
|P||F||Portfolio Manager (basic)|
|P||F||Morningstar Investment Classroom|
|P||F||Access Your Portfolio Anytime, Anywhere via Your Mobile Device|
|P||Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)|
|P||Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)|
|P||Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)|
|P||Portfolio Monitor (monthly and on-demand personalized portfolio statements)|
|P||Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)|
|P||Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters|
|P||Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)|
|P||Discounts on Morningstar newsletters, books, seminars, and more|
Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.
Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.